DULUTH, Ga.–(BUSINESS WIRE)–National Vision, Inc., one of the largest optical retail companies in the U.S. providing quality, affordable eye care and eyewear, announced today the winners of its ninth annual scholarship program, fueling the success of…
Author: Business Wire
US Eye Chief Medical Officer Dr. Kerry Solomon Honored with AECOS Award
BRADENTON, Fla.–(BUSINESS WIRE)– #AECOS–The American-European Congress of Ophthalmic Surgery (AECOS) has named Kerry Solomon, M.D. as the 2024 recipient of its prestigious Dulaney Award.
STAAR Surgical Adds Arthur Butcher and Wei Jiang to Board of Directors
LAKE FOREST, Calif.–(BUSINESS WIRE)–STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of the EVO family of Implantable Collamer® Lenses (ICL) for myopia, astigmatism and presbyopia, today announced the appointment …
Alcon Strengthens Leadership in IOL Innovation with the launch of the Clareon Presbyopia Correcting IOLs in India
BENGALURU, India–(BUSINESS WIRE)–The release will introduce Alcon’s latest Intraocular Lens technology in India
GenSight Biologics Announces Initial Results from New Meta-Analyses on Visual Outcomes with LUMEVOQ® Gene Therapy at NANOS 2024
PARIS–(BUSINESS WIRE)–Regulatory News: GenSight Biologics (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on developing and commercializing innovative gene therapies for retinal neurodegenerative diseases and cent…
RG6501 (OpRegen®) Preclinical Engraftment Results to Be Presented at 2024 Association for Research in Vision and Ophthalmology Meeting
CARLSBAD, Calif.–(BUSINESS WIRE)—- $LCTX #LineageCellTherapeutics–Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic cell therapies for unmet medical needs, today announced t…
Graphite Bio Declares Special Dividend In Connection with Proposed Merger with Lenz Therapeutics
SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)—- $GRPH #GraphiteBio–Graphite Bio, Inc. (Nasdaq: GRPH) (“Graphite” or the “Company”) today announced that its Board of Directors has declared a special dividend in connection with the previously announced…
Nordic Eyewear Market Insights & Forecasts Report 2024-2028 with Competitive Analysis of Grand Vision, Synsam, Specsavers, Synologen, Optik Team, and Krogh Optikk – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Nordic Eyewear Market (Sweden, Denmark, Norway & Finland): Insights & Forecast with Potential Impact of COVID-19 (2024-2028)” report has been added to ResearchAndMarkets.com’s offering. The Nordic eyewear market is…
Lineage Cell Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
CARLSBAD, Calif.–(BUSINESS WIRE)—- $LCTX #LineageCellTherapeutics–Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic cell therapies for unmet medical needs, today reported it…
Nouveauté Suisse pour faciliter la sélection des lentilles dans la chirurgie de la cataracte
NEUCHÂTEL, Suisse–(BUSINESS WIRE)–La société Swiss Advanced Vision (SAV-IOL SA) a annoncé le lancement de nouvelles fonctionnalités pour son Calculateur torique, améliorant l’expérience globale de calcul. Pour la première fois, les ophtalmologues pou…
Viridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
WALTHAM, Mass.–(BUSINESS WIRE)–Viridian Therapeutics, Inc. (Nasdaq: VRDN) (the “company” or “Viridian”), a biopharmaceutical company focused on discovering and developing potential best-in-class medicines for serious and rare diseases, today announce…
MediPrint® Ophthalmics Announces Successful Completion of Its Phase 2b Glaucoma Clinical Study with Positive Results.
SAN DIEGO–(BUSINESS WIRE)–MediPrint® Ophthalmics, a clinical-stage ocular drug delivery platform technology focused on transforming ocular drug delivery, announces the completion of its Glaucoma SIGHT-2, Phase 2b study. The Phase IIb trial was an act…
Vivity, the World’s Leading EDOF IOL, Reaches One Million Milestone
TORONTO–(BUSINESS WIRE)–Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today proudly announces AcrySof® IQ Vivity® and Clareon® Vivity extended depth of focus (EDOF) intraocular lens (IOL) has surpas…
Vivity, la LIO à profondeur focale accrue première au monde, atteint un million d’implants
TORONTO–(BUSINESS WIRE)–Alcon (SIX/NYSE : ALC), le chef de file mondial en matière de soins oculaires qui se consacre à aider les gens à voir brillamment, annonce aujourd’hui fièrement que les lentilles intraoculaires (LIO) à profondeur focale accrue…
Vivity, the World’s Leading EDOF IOL, Reaches One Million Milestone
FORT WORTH, Texas–(BUSINESS WIRE)–Vivity, the World’s Leading EDOF IOL, Reaches One Million Milestone
Telios Pharma Announces Successful Phase 2 Results for TL-925, a Novel Treatment for Dry Eye Disease
REDWOOD CITY, Calif.–(BUSINESS WIRE)–Telios Pharma, Inc., a clinical stage biopharmaceutical company committed to improving the lives of patients with inflammatory diseases, today announced topline results from its Phase 2 study assessing TL-925, a f…
National Vision Holdings, Inc. Announces Participation in the UBS Global Consumer and Retail Conference
DULUTH, Ga.–(BUSINESS WIRE)–National Vision Holdings, Inc. (NASDAQ: EYE) today announced that Reade Fahs, chief executive officer, and Melissa Rasmussen, chief financial officer, will participate in a fireside chat at the UBS Global Consumer and Reta…
STAAR Surgical to Participate in Two Upcoming Investor Conferences
LAKE FOREST, Calif.–(BUSINESS WIRE)–STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of the EVO family of Implantable Collamer® Lenses (EVO ICL™) for myopia, astigmatism and presbyopia, today announced that manage…
SDC Optimizes Focus on Tech-Enabled Biometric Services
PHOENIX–(BUSINESS WIRE)–Statistics & Data Corporation (SDC), a global leader in life sciences biometrics services and technology solutions, announces a strategic decision to enhance focus and efficiency by transitioning its ophthalmic biometric d…
Viridian Therapeutics to Participate in the Leerink Partners Global Biopharma Conference
WALTHAM, Mass.–(BUSINESS WIRE)–Viridian Therapeutics, Inc. (NASDAQ: VRDN), a biopharmaceutical company focused on discovering and developing potential best-in-class medicines for serious and rare diseases, today announced that senior management will …